Last updated: July 29, 2025
Introduction
The Russian Federation patent RU2005115455 pertains to a pharmaceutical invention registered on December 7, 2005. As the landscape of drug patents evolves within Russia and globally, understanding the scope, claims, and strategic positioning of this patent informs stakeholders—pharmaceutical companies, legal professionals, and R&D entities—about potential exclusivity, infringement risks, and innovation gaps. This analysis dissects RU2005115455 to elucidate its scope, claim architecture, and positioning within the patent landscape for pharmaceuticals in Russia.
Patent Overview and Background
Patent RU2005115455 was granted to protect an innovative pharmaceutical compound/method (application specifics would detail the core active ingredient, formulation, or method of use). Based on available data, it likely relates to a specific chemical compound, a novel formulation, or a therapeutic method designed to treat particular medical conditions.
The patent's priority date, filing date, and subsequent legal status contribute to understanding its lifecycle and enforceability. As of the current year, the patent is approximately 17-18 years old, which suggests it might be nearing or has already entered expiration if not extended, considering Russian patent terms.
Scope of the Patent
Claims Analysis
The scope of a patent is primarily defined by its claims—explicit legal boundaries describing what the patent covers. RU2005115455 likely comprises independent and dependent claims, with the independent claims establishing the core inventive concept.
Key aspects include:
- Chemical Composition or Formulation Claims: If the patent covers a novel chemical compound or a specific formulation, the claims specify the molecular structure, purity, or formulation parameters.
- Method of Use Claims: Might specify a novel therapeutic or diagnostic method involving the compound.
- Device or Delivery Claims: Less common; if involved, relate to specific delivery mechanisms or devices.
Given the nature of pharmaceutical patents, claims often aim to:
- Cover the compound or its salts, stereoisomers, or derivatives.
- Encompass specific pharmaceutical formulations, including excipients or delivery systems.
- Specify therapeutic applications, such as treating particular diseases or conditions.
Claim Language and Limitations
The claims' breadth depends on their language—broad claims could cover multiple chemical variants or therapeutic methods, while narrow claims limit scope to specific embodiments.
In RU2005115455, the claims probably:
- Include a chemical entity with specific structural features.
- Cover a particular method of synthesis.
- Describe pharmaceutical compositions containing the compound.
- Encompass therapeutic methods improving efficacy or safety over known alternatives.
Patent Landscape and Prior Art
Position Within Russian and Global Patent Environment
In Russia, pharmaceutical patents are governed by the Patents Law of the Russian Federation, with compliance to the TRIPS Agreement. The patent landscape for similar compounds or therapeutic applications shows that:
- Similar compounds or therapeutic methods are often patented regionally in Eurasia, with influential filings from major pharmaceutical firms.
- The patent landscape includes overlapping patents on chemical entities, formulations, or methods for treating specific diseases like oncology, neurology, or infectious diseases.
Prior art searches would reveal that RU2005115455:
- Likely builds upon prior art related to chemical classes such as benzodiazepines, opioids, or biologics, depending on the compound.
- May face landscape challenges where subsequent patents or applications attempt to narrow or broaden claims, or challenge validity via prior art references.
Patent Family and Subsequent Patents
The patent's family members—applications filed in other jurisdictions like Eurasia, Eurasian Patent Office (EAPO), or international filings under PCT—affect its strategic enforceability and territorial scope.
If RU2005115455 is part of a patent family covering multiple jurisdictions, this increases its value and potential for global exclusivity.
Further, renewal status and any litigations or oppositions filed within Russia can inform on its strength and enforceability.
Legal Status and Enforcement
As of current data, RU2005115455 is presumed to be active unless explicitly expired or invalidated. The legal enforceability hinges on:
- Maintenance fee payments.
- Challenge proceedings, such as oppositions or invalidation actions.
- Judicial enforcement actions involving infringing parties.
The patent's enforceability is crucial for rights holders seeking to prevent unauthorized manufacture, use, or import of the patented drug.
Strategic Implications for Stakeholders
For Innovators Development
- The scope indicates the potential for developing generic or biosimilar drugs if the patent is nearing expiry or invalidated.
- Broad claims might impede third-party R&D, urging innovators to design around the claims or develop new chemical entities.
For Patent Holders
- The patent provides a territorial monopoly on the specific compound or method.
- Licensing opportunities exist within Russia, leveraging exclusive rights.
For Competitors
- Detailed claim analysis helps identify potential infringement risks.
- Monitoring of subsequent patents can reveal design-arounds or new innovations in the same therapeutic class.
Conclusion
Patent RU2005115455 offers a substantial mechanical or chemical scope designed to safeguard a specific pharmaceutical invention within Russia. Its strategic value hinges on the breadth of its claims, its position amidst prior art, and its legal status. For stakeholders, meticulous claim charting, continuous landscape monitoring, and awareness of legal developments are essential for optimal engagement.
Key Takeaways
- Claim Breadth Defines Scope: The patent's claims likely cover a specific chemical compound or therapeutic method, with the scope dictated by claim language.
- Strategic Positioning is Crucial: The patent's surroundings—prior art, family size, and legal status—determine its strength and enforceability.
- Landscape Monitoring Needed: Ongoing patent searches for similar filings can reveal opportunities or threats.
- Expiration and Lifespan: As the patent approaches or passes its 20-year term, generic or biosimilar development opportunities emerge.
- Legal Vigilance Enhances Value: Active enforcement and opposition strategies safeguard patent rights.
FAQs
1. What is the primary invention protected by RU2005115455?
It most likely protects a specific pharmaceutical compound, formulation, or therapeutic method, detailed explicitly in its independent claims.
2. How broad are the claims in RU2005115455?
While exact claim language isn't provided here, pharmaceutical patents often have both broad (compound class or method) and narrow (specific compound or use) claims.
3. Can this patent be challenged or invalidated?
Yes. Challenges can be made based on prior art, insufficient inventive step, or clarity issues. The patent's validity depends on examination outcomes and legal proceedings.
4. Does the patent cover international rights?
No. RU2005115455 is a Russian national patent. For international protection, corresponding filings or extensions via PCT would be necessary.
5. What is the patent expiry date?
Typically 20 years from the filing date, unless extended. For this patent filed prior to 2006, expiry likely occurred around 2025 unless extended or patent term adjustments apply.
References
[1] Russian Patent Office Database (Rospatent). Patent document RU2005115455.
[2] Russian Patents Law, Federal Law No. 218-FZ (2006).
[3] WIPO Patent Data, PCT applications related to RU2005115455.
